1. Home
  2. OLMA vs NXRT Comparison

OLMA vs NXRT Comparison

Compare OLMA & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • NXRT
  • Stock Information
  • Founded
  • OLMA 2006
  • NXRT 2014
  • Country
  • OLMA United States
  • NXRT United States
  • Employees
  • OLMA N/A
  • NXRT N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • NXRT Real Estate Investment Trusts
  • Sector
  • OLMA Health Care
  • NXRT Real Estate
  • Exchange
  • OLMA Nasdaq
  • NXRT Nasdaq
  • Market Cap
  • OLMA 465.4M
  • NXRT 1.2B
  • IPO Year
  • OLMA 2020
  • NXRT N/A
  • Fundamental
  • Price
  • OLMA $6.10
  • NXRT $42.45
  • Analyst Decision
  • OLMA Strong Buy
  • NXRT Buy
  • Analyst Count
  • OLMA 5
  • NXRT 5
  • Target Price
  • OLMA $26.25
  • NXRT $49.00
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • NXRT 96.7K
  • Earning Date
  • OLMA 11-12-2024
  • NXRT 02-18-2025
  • Dividend Yield
  • OLMA N/A
  • NXRT 4.80%
  • EPS Growth
  • OLMA N/A
  • NXRT 54.64
  • EPS
  • OLMA N/A
  • NXRT 1.77
  • Revenue
  • OLMA N/A
  • NXRT $264,974,000.00
  • Revenue This Year
  • OLMA N/A
  • NXRT N/A
  • Revenue Next Year
  • OLMA N/A
  • NXRT $0.54
  • P/E Ratio
  • OLMA N/A
  • NXRT $24.01
  • Revenue Growth
  • OLMA N/A
  • NXRT N/A
  • 52 Week Low
  • OLMA $5.56
  • NXRT $28.20
  • 52 Week High
  • OLMA $16.78
  • NXRT $48.37
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • NXRT 35.23
  • Support Level
  • OLMA $5.56
  • NXRT $45.38
  • Resistance Level
  • OLMA $6.87
  • NXRT $46.15
  • Average True Range (ATR)
  • OLMA 0.81
  • NXRT 1.24
  • MACD
  • OLMA -0.28
  • NXRT -0.57
  • Stochastic Oscillator
  • OLMA 10.12
  • NXRT 23.86

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

Share on Social Networks: